|
USP47 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.778670E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.435480E-04 |
| Normal-vs-Stage2 |
4.032000E-02 |
| Normal-vs-Stage3 |
1.685640E-01 |
| Normal-vs-Stage4 |
9.784600E-04 |
| Stage1-vs-Stage2 |
8.544200E-01 |
| Stage1-vs-Stage3 |
2.976800E-01 |
| Stage1-vs-Stage4 |
5.625000E-01 |
| Stage2-vs-Stage3 |
5.267600E-01 |
| Stage2-vs-Stage4 |
4.620200E-01 |
| Stage3-vs-Stage4 |
2.231800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.75270000000372E-05 |
| Normal-vs-AfricanAmerican |
4.280200E-02 |
| Normal-vs-Asian |
4.997400E-01 |
| Caucasian-vs-AfricanAmerican |
2.825200E-01 |
| Caucasian-vs-Asian |
3.632100E-02 |
| AfricanAmerican-vs-Asian |
1.470400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.22379999970101E-07 |
| Normal-vs-Female |
7.574400E-01 |
| Male-vs-Female |
9.52810000000026E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.672300E-02 |
| Normal-vs-Extreme_Weight |
2.23380000052842E-07 |
| Normal-vs-Obese |
6.377600E-02 |
| Normal-vs-Extreme_Obese |
2.208200E-04 |
| Normal_Weight-vs-Extreme_Weight |
5.293800E-02 |
| Normal_Weight-vs-Obese |
8.859200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.684200E-02 |
| Extreme_Weight-vs-Obese |
1.557640E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.895400E-01 |
| Obese-vs-Extreme_Obese |
5.247500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.779400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.384300E-02 |
| Normal-vs-Age(61-80Yrs) |
4.87660000048074E-07 |
| Normal-vs-Age(81-100Yrs) |
2.644100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.543600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.772900E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.066300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.121200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.104560E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.236600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.50091999999713E-05 |
| Normal-VS-Type2 PRCC |
1.943860E-03 |
| Normal-VS-KIRP CIMP |
4.082800E-01 |
| Normal-VS-Unclassified PRCC |
4.757400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.953600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.557700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.430390E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.383900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.988630E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.922600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.89119999999865E-05 |
| Normal-vs-N1 |
8.657600E-01 |
| Normal-vs-N2 |
3.520000E-02 |
| N0-vs-N1 |
6.124500E-03 |
| N0-vs-N2 |
9.631200E-01 |
| N1-vs-N2 |
2.812200E-01 |
|
|
